Answer
Twinrix Paediatric is indicated for non-immune infants, children and adolescents aged 1 through 15 years inclusive who are at risk of both hepatitis A and hepatitis B infection, which it helps prevent.
Sources for this answer
- Twinrix Paediatric Vaccine suspension for injectionGlaxoSmithKline UK · emc · SmPC §4.1 Therapeutic Indications · Version 20Document updated
Sources checked